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The aim of this study was to assess the effect of locally administered prostaglandin E1 on peripheral
nerve regeneration and functional recovery. Sixty male healthy white Wistar rats were divided into four
experimental groups (n ¼ 15), randomly: In transected group (TC), left sciatic nerve was transected and
stumps were ﬁxed in the adjacent muscle. In treatment group defect was bridged using silicone graft
(SIL/PE) ﬁlled with 10 mL prostaglandin E1. In silicone graft group (SIL), the graft was ﬁlled with
phosphate-buffered saline alone. In sham-operated group (SHAM), sciatic nerve was exposed and
manipulated. Each group was subdivided into three subgroups of ﬁve animals each and regenerated
nerve ﬁbers were studied 4, 8 and 12 weeks after surgery. Behavioral testing, sciatic nerve functional
study, gastrocnemius muscle mass and morphometric indices conﬁrmed faster recovery of regenerated
axons in SIL/PE than SIL group (p < 0.05). In immunohistochemistry, location of reactions to S-100 in SIL/
PE was clearly more positive than that in SIL group. When loaded in a silicone graft, prostaglandin E1
improved functional recovery and morphometric indices of sciatic nerve. Local application of prosta-
glandin E1 improved functional recovery and morphometric indices of sciatic nerve.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Where there is considerable nerve tissue loss, peripheral nerve
regeneration is still a concern in regenerative medicine.1 When an
axon is crushed or severed, changes occur on both sides of the
lesion.2 Where a gap is present between the severed ends of the
nerve, proliferating Schwann cells emerge from the stumps (mainly
the distal stump) and form a series of nucleated cellular cords (the
bands of Bungner) which bridge the interval.3
Followingnerve transectionWalleriandegenerationoccurswhich
is a sequential pattern of axonal degeneration, myelin degradation
and supporting glial cell proliferation. During this process, various
events take place, including blood-nerve barrier dysfunction, endo-
neural space reorganization, and most importantly the induction of
an intense inﬂammatory response, constituted by inﬂammatory
mediator release and production.4,5
Axonal degeneration recruits this response activating Schwann
cells and macrophages that proliferate and activate, clearing myelin
debris and producing cytokines that perpetuate an inﬂammatory: þ98 441 2622702.
our).
ciates Ltd. Published by Elsevier Ltstate. Axonal regeneration is then regulated by the interactions
between all the involved cell types and by cytokines, chemokines,
growth factors, and other inﬂammatory mediators.5 All these events
culminate in the promotion of an environment suitable for subse-
quent regeneration, repair, and axon regrowth. Arachidonic acid and
its metabolites are known to modulate neuronal function and sur-
vival. There is also evidence that arachidonic acid derivatives, such as
prostaglandins, are centrally involved inWallerian degeneration and
in axonal regeneration.5
Regarding the association that exists between arachidonic acid
derivatives and nerve degeneration and regeneration, the thera-
peutic modulation of this pathway emerges as a novel strategy
aimed at increased motor, sensory, and structural recovery after
nerve injury.6
Aimed to study local effects of prostaglandin E1(PGE 1) on
peripheral nerve regeneration, the present study was designed
to attempt to determine if topical PGE 1 do in fact reduce
dysfunction after small gap nerve transection injury in the rat
sciatic nerve transection model. Assessment of nerve regenera-
tion was based on behavioral, functional (walking track analysis),
histomorphometrical and immunohistochemical (Schwann cell
detection by S100 expression) assessment at 4, 8, and 12 weeks
after surgery.d. All rights reserved.
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2.1. Study design and animals
Sixty male Wistar rats weighing approximately 290 g were divided into four
experimental groups (n ¼ 20), randomly: sham-operation group as normal con-
trol (SHAM), transected control (TC), silicone graft (SIL) and prostaglandin E1
treated group (SIL/PE). Each group was further subdivided into three subgroups of
ﬁve animals each and surveyed 4, 8 and 12 weeks after surgery. Two weeks
before and during the experiments, the animals were housed in individual plastic
cages with an ambient temperature of (23  3) C, stable air humidity and a
natural day/night cycle. The rats had free access to standard rodent laboratory
food and tap water. All measurements were made by two blinded observers
unaware of the analyzed groups.
2.2. Surgical procedure
Animals were anesthetized by intraperitoneal administration of ketamine-
xylazine (ketamine 5%, 90 mg/kg and xylazine 2%, 5 mg/kg). The procedure was
carried out based on the guidelines of the Ethics Committee of the International
Association for the Study of Pain.7 The University Research Council approved all
experiments.
Following surgical preparation in the sham-operation group, the left sciatic
nerve was exposed through a gluteal muscle incision and after careful homeostasis
the muscle was sutured with resorbable 4/0 sutures, and the skin with 3/0 nylon. In
TC group, the left sciatic nerve was transected proximal to the tibio-peroneal
bifurcation where a 7 mm segment was excised, leaving a 10 mm gap due to
retraction of nerve ends. Proximal and distal stumps were ﬁxed in the adjacent
muscle with 10/0 nylon epineurial suture. No graft was interposed between the
stumps. In the SIL group, a 7 mm nerve segment was resected to produce a 10 mm
nerve gap after retraction of the nerve transected ends. The gap was bridged using a
silicone graft (Polyerubb Industries, Ahmedabad e 380023, Gujarat, India), entu-
bulating 2 mm of the nerve stump at each end. The graft was 14 mm in length, 2 mm
in inner diameter and 2 mm in thickness. A subtle retraction of 1 mm was already
expected. Two 10/0 nylon sutures were used to anchor the graft to the epineurium at
each end. In prostaglandin E1 treated group (SIL/PE) the graft was ﬁlled with 10 ml
prostaglandin E1 (100 ng/mL) (SigmaeAldrich Chemie GmbH, Steinheim, Germany).
The animals were anesthetized and euthanized with transcardiac perfusion of a
ﬁxative containing 2% paraformaldehyde and 1%glutaraldehyde buffer (pH 7.4) 4, 8
and 12 weeks after surgery.
2.3. Behavioral testing
Functional recovery of the nerve was assessed using the Basso, Beattie, and
Bresnahan (BBB) locomotor rating scale for rat hind limb motor function.8 Although
BBB is widely used to assess functional recovery in spinal cord injured animals,
however, it has been demonstrated that it could be most useful in assessment of
never repair processes in peripheral nerve injuries.9 Scores of 0 and 21 were given
when therewere no spontaneous movement and normal movement, respectively. A
score of 14 shows full weight support and complete limbs coordination.8,9 BBB
recordings were performed by a trained observer who was blinded to the experi-
mental design. The animals were observed and assessed within a course of a 4-min
exposure to an open area of a mental circular enclosure. BBB scores were recorded
once before surgery in order to establish a baseline control and again weekly
thereafter to assess functional recovery during 12 weeks.
2.4. Functional assessment of reinnervation
2.4.1. Sciatic functional index (SFI)
Walking track analysis was performed 4, 8 and 12 weeks after surgery based on
the method of others.10 The lengths of the third toe to its heel (PL), the ﬁrst to the
ﬁfth toe (TS), and the second toe to the fourth toe (IT) were measured on the
experimental side (E) and the contralateral normal side (N) in each rat. The sciatic
function index (SFI) of each animal was calculated by the following formula:
SFI ¼ 38:3 ðEPL  NPLÞ=NPL þ 109:5 ðETS NTSÞ=NTSþ 13:3
 ðEIT NITÞ=NIT 8:8
In general, SFI oscillates around 0 for normal nerve function, whereas
around 100 SFI represents total dysfunction. SFI was assessed in the NC group and
the normal level was considered as 0. SFI was a negative value and a higher SFI
meant the better function of the sciatic nerve.
2.4.2. Static sciatic index (SSI)
SSI is a time-saving digitized static footprint analysis described by others.11 A
good correlation between the traditional SFI and the newly developed static sciatic
index (SSI) and static toe spread factor (TSF), respectively, has been reported by
others.11 The SSI is a time-saving and easy technique for accurate functionalassessment of peripheral nerve regeneration in rats and is calculated using the static
factors, not considering the print length factor (PL), according to the equation:
SSI ¼ ½ð108:44 TSFÞ þ ð31:85 ITSFÞ  5:49
where:
TSF ¼ (ETSNTS)/NTS
ITSF ¼ (EITNIT)/NIT
Like SFI, an index score of 0 was considered normal and an index of 100
indicated total impairment. When no footprints were measurable, the index score
of 100 was given.312.5. Muscle mass
Recovery assessment was also indexed using the weight ratio of the gastroc-
nemius muscles 12 weeks after surgery. Immediately after sacriﬁcing of animals,
gastrocnemius muscles were dissected and harvested carefully from intact and
injured sides and weighed while still wet, using an electronic balance.2.6. Histological preparation and morphometric studies
Nerve mid-substance in SIL group, nerve mid-substance in prostaglandin E1
treated group, midpoint of normal sciatic nerve (SHAM) and regenerated mid sub-
stance of TC group were harvested and ﬁxed with glutaraldehyde 2.5%. They were
post ﬁxed in OsO4 (2%, 2 h), dehydrated through an ethanol series and embedded in
Epon. The nerves were cut in 5 mm in the middle, stained with toluidine blue and
examined under light microscopy. Morphometric analysis was carried out using an
image analyzing software (Image-Pro Express, version 6.0.0.319, Media Cybernetics,
Silver Springs, MD, USA). Equal opportunity, systematic random sampling and two-
dimensional dissector rules were followed in order to cope with sampling-related,
ﬁber-location-related and ﬁber-size related biases.122.7. Immunohistochemical analysis
In this study, anti-S-100 (1:200, DAKO) was used as marker for myelin sheath.
Specimens prior to immunohistochemistry were post ﬁxed with 4% para-
formaldehyde for 2 h and embedded in parafﬁn. Then the nerve sections were
dewaxed and rehydrated in PBS (pH ¼ 7.4). They were incubated by 0.6% hydrogen
peroxide for half an hour to neutralize endogenous peroxide. After that the sections
were incubated with normal swine serum (1: 50, DAKO, Germany) for blocking of
non-speciﬁc immunoreactions and then were incubated in S-100 protein antibody
solution for 1 h at room temperature. They were washed three times with PBS and
incubated in biotynilated anti-mouse rabbit IgG solution for 1 h. Horseradish
peroxidase-labeled secondary antibody (1:100 swine anti-rabbit diluted in 5%
normal rat serum) was applied for 1 h. All sections were then incubated with
diaminobenzidine tetrahydrochloride chromogen (DAB, DAKO) substrate solution
for 10min. The sections weremounted in corbit balsamwith coverslip. The results of
immunohistochemistry were examined under a light microscope.2.8. Statistical analysis
The results were expressed as means  SD. Statistical analyses were per-
formed using PASW 18.0 (SPSS Inc., ChicSILo, IL, USA). Model assumptions were
evaluated by examining the residual plot. Results were analyzed using a factorial
ANOVA with two between-subjects factors. Bonferroni test for pairwise com-
parisons was used to examine the effect of time and treatments. The differences
were set at P < 0.05.3. Results
3.1. BBB recovery
In order to assess hind limb recovery the open ﬁeld locomotor
was used. Fig. 1 shows BBB scores compared to the baseline. All
experimental groups, except for sham, showed the greatest degree
of functional deﬁcit one week after surgery. The prostaglandin E1
treated group showed signiﬁcant improvement in locomotion of
the operated limb compared to the SIL group during the study
period (P < 0.05).
Fig. 3. Bar graph indicating static sciatic index (SSI) values in each experimental group
during the study period. Topical administration of PGE 1 with silicone grafting gave
better results in functional recovery of the sciatic nerve than in SIL group. Data are
presented as mean  SD. *P < 0.05 vs SIL group.
Fig. 1. BBB score for all experimental groups. Topical administration of PGE1 with
silicone grafting gave better scores than in SIL group. Standard error at each data point
is shown with bars. *P < 0.05 vs SIL group.
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3.2.1. SFI outcome
Fig. 2 shows sciatic function index (SFI) values in experimental
groups. Prior to surgery, SFI values in both groups were near zero.
After the nerve transection, the mean SFI decreased to 100 due to
the complete loss of sciatic nerve function in all animals. At the end
of the study period, animals of PGE 1 treated group achieved a
mean value for SFI of 41.3  2.45 whereas in SIL group a mean
value of 58  2.42 was found. The statistical analyses revealed
that the recovery of nerve function was signiﬁcantly (P < 0.05)
different between SIL and SIL/PE groups and application of PGE 1 in
silicone conduit signiﬁcantly improved functional recovery in the
course of time.
3.2.2. SSI outcome
Changes in SSI were similar to those observed in SFI, indicating
signiﬁcant deﬁcit following the sciatic nerve transection (Fig. 3).Fig. 2. Box-and-whisker plots of sciatic nerve function index values in each experi-
mental group during the study period. Topical administration of PGE1 with silicone
grafting gave better results in functional recovery of the sciatic nerve than in SIL group.
Topical administration of PGE 1 with silicone grafting gave better results in functional
recovery of the sciatic nerve than in SIL group (P < 0.05).Changes in SSI were signiﬁcant at weeks 4, 8 and 12 weeks of
recovery (P < 0.05). The contrasts indicated SSI values at week 12
to differ signiﬁcantly from those obtained from control, a trend
also noticed for SFI (P < 0.05).
3.3. Muscle mass measurement
The mean ratios of gastrocnemius muscle weight were
measured at the end of the study period. There was a statistically
signiﬁcant difference between the muscle weight ratios of the SIL/
PE and SIL groups (P < 0.05). The results showed that in the pros-
taglandin E1 treated group, the muscle weight ratio was larger than
in the SIL group, and weight loss in the gastrocnemius muscle was
ameliorated by prostaglandin E1 topical administration (Fig. 4).
3.4. Histological and morphometric ﬁndings
Figs. 5e7 show the quantitative morphometric analyses of
regenerated nerves for each of the experimental groups. The
prostaglandin E1 treated group presented signiﬁcantly greater
nerve ﬁber, axon diameter, and myelin sheath thickness 4 weeks
after surgery, compared to SIL animals (P < 0.05). Sham-operation
group presented signiﬁcantly greater nerve ﬁber and axon diam-
eter, and myelin sheath thickness compared to SIL/PE and SIL
groups animals. In case of myelin thickness there was no signiﬁcant
difference between SIL/PE and SIL groups, morphometrically
(P > 0.05).Fig. 4. Gastrocnemius muscle weight measurement. The gastrocnemius muscles of
both sides (operated left and unoperated right) were excised and weighed in the
experimental groups at 12 weeks after surgery. Data are presented as mean  SD.
*P < 0.05 vs SIL group.
Fig. 5. The graph shows the quantitative results of ﬁber counting. The mean number of
nerve ﬁbers in SHAM group was nearly 8276  189 (mean  SD). Both groups of SIL
and SIL/PE showed the lower number of ﬁbers than the sham-operated group even at
the end of the study period. Data are presented as mean  SD. *P < 0.05 vs SIL group.
Fig. 7. The graph shows the quantitative results of mean thickness of myelin sheath.
The mean thickness of myelin sheath in SHAM group was nearly 2.3  0.06
(mean  SD). Both groups of SIL and SIL/PE showed the lower mean diameter of axons
than the sham operated group even at the end of the study period.
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Immunoreactivity to S-100 protein was extensively observed in
the cross sections of regenerated nerve segments. The expression of
S-100 protein signal was located mainly in the myelin sheath. The
axon also showed a weak expression indicating that Schwann cell-
like phenotype existed around the myelinated axons (Fig. 8). In
both SIL/PE and SIL groups, the expression of S-100 and the ﬁndings
resembled those of the histological evaluations.4. Discussion
Entubulation neurorrhaphy is an excellent alternative to short
interposition nerve grafts.13 In the present study silicone tube was
used as a scaffold for keeping the delivered drug in situ. Selection of
an appropriate method to evaluate functional recovery of nerve
regeneration is extremely inﬂuential. In this study, we did not
perform nerve conduction tests because electrophysiological
studies have poor correlation with functional indices.14 Nerve
conduction velocity and peak action potential amplitude do not
evaluate total nerve function but a fraction of nerve ﬁbersFig. 6. The graph shows the quantitative results of mean diameter of nerves ﬁbers. The
mean diameter of nerve ﬁbers in SHAM group was nearly 12.5  0.19 (mean  SD).
Both groups of SIL and SIL/PE showed the lower mean diameter of nerve ﬁbers than the
sham-operated group even at the end of the study. Data are presented as mean  SD.
*P < 0.05 vs SIL group.population. Compound action potential is derived from extrinsic
direct nerve excitation and does not correlate with proper central
or peripheral connections.15 Castaneda et al.,16 suggested that
arrival of sprouts from the proximal stump at the distal nerve
stump does not necessarily imply recovery of nerve function.
Information taken from BBB scale may be invaluable in evaluation
of peripheral nerve process. Results of the present study showed
that prostaglandine treated animals had been improved in loco-
motion of the operated limb compared to the control group during
the study period. Walking track analysis and static sciatic index has
frequently been used to reliably determine functional recovery
following nerve repair in rat models.10,11,17 The present study again
showed similar results taken from both SFI and SSI assessments.
Walking is a coordinated activity involving sensory input, motor
response and cortical integration.18 Therefore, walking track anal-
ysis, sciatic function index, is a comprehensive test. As the posterior
tibial branch of the sciatic nerve regenerates into the gastrocne-
mius muscle, it will regain its mass proportional to the amount of
axonal reinnervation.19,20 In the present study 12 weeks after sur-
gery the muscle mass was found in both experimental groups.
However, SIL/PGE group showed signiﬁcantly greater ratios of the
mean gastrocnemius muscle weight than SIL group indicating
indirect evidence of successful end organ reinnervation.
Although both morphological and functional data have been
used to assess neural regeneration after induced crush injuries, the
correlation between these two types of assessment is usually
poor.15,21,22 Classical and newly developed methods of assessing
nerve recovery, including histomorphometry, retrograde transport
of horseradish peroxidase and retrograde ﬂuorescent labeling23,24
do not necessarily predict the reestablishment of motor and sen-
sory functions .16,25,26 Although such techniques are useful in
studying the nerve regeneration process, they generally fail in
assessing functional recovery.22 Therefore, research on peripheral
nerve injury needs to combine both functional and morphological
assessment.
A wide variety of materials have been used to produce nerve
guides, including non-biodegradable and biodegradable materials.
Because of its inert and elastic properties, the silicon tube was one
of the ﬁrst and most frequently used to bridge the transected
nerves.27
After nerve injury, increased cyclooxygenase expression induces
the production of PG in nerve terminals and nonneural cells in the
surrounding areas. This process is known to initiate hyperalgesia and
neuropathic pain.28,29 Prostaglandins are produced in important
Fig. 8. Immunohistochemical analysis of the regenerated nerves 12 weeks after surgery from (A) middle cable TC, (B) SIL/PE and (C) SIL. There is clearly more positive staining of the
myelin sheath-associated protein S-100 (arrows) within the periphery of nerve, indicating well organized structural nerve reconstruction in prostaglandin E1 treated nerve
compared to that of the SIL. Scale bar: 10 mm.
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nerves and macrophages in response to soluble factors produced by
injured nerves.30 It has been shown that prostanoid receptors,
effectors of biological actions of prostaglandins, are expressed in
Schwann cells and could modulate Schwann cell function in vivo.31
Morover, it has been shown that prostaglandin E2 could modulate
microglial migration and function.32 Prostaglandins have also been
shown that interact with nerve growth factor in the regulation of
inﬂammatory responses and degeneration following injury.33 After
nerve injury prostaglandins play a crucial role in nerve degeneration
and regeneration. These are vasoactive molecules and their action in
blood-ﬂowhomeostasis and inﬂammation during nerve injury could
be important. Prostaglandin E1 diminishes peripheral nerve
ischemia-reperfusion injury, probably through such a mechanism.34
Following nerve crush injury, PG E1treatment has resulted in
reduced injury, increased repair rates and the upregulation of
vascular endothelial growth factor.35 Schratzberger et al.,36 showed
that vascular endothelial growth factor gene transfer signiﬁcantly
increased nerve blood ﬂow as well as the amount of vasculature in
nerves, suggesting that the induction of local angiogenesis amelio-
rates experimental neuropathy. One mechanism that PGE1 can
promote the repair of peripheral nervewith crushing lesion, could be
via increasing the expression of vascular endothelial growth factor.35
It has been reported by clinical and experimental studies that vaso-
active treatment can alleviate the effects of lesions in peripheral
nerves.37,38
The induction of neuronal apoptosis is a recognized phenomenon
after nerve injury that contributes to the physiopathology of nerve
degeneration. The administration of PGE1 inhibits neuronal
apoptosis in the spinal cord after sciatic nerve constriction injury,
independently of changes in local blood ﬂow.39 This suggests that
neuroprotective mechanism of PG E1 is not solely dependent on its
vasoactive properties. Apart from hyperalgesia and blood-ﬂow
regulation, prostaglandins also reported to contribute to the molec-
ular and cellular process of nerve degeneration and regeneration.6
Further studies on sciatic nerve crush injury also showed that
PGE1 both reduced apoptosis and improved neuronal regenera-
tion.40 Prostaglandins are known to modulate the upregulation of
heat-shock protein-70 expression, a protein response known to
participate in the maintenance of neuron survival after nerve
injury.41,42 After nerve injury, macrophages migrate into the area
and initiate degenerative and regenerative processes.
Even though our preliminary study shows the neuroprotective
action of local prostaglandin E1 in peripheral nerve injuries, data
regarding the molecular mechanisms leading to the neuro-
protective action is limited and the exact mechanisms are just be-
ing uncovered. We have not given the histological and molecular
evidence for neuroprotective action of prostaglandin E1. This may
be considered as a limitation to our study. Therefore, the authors
stress that the aim of the current investigation was to evaluate asingle local dose and clinical treatment potential of prostaglandin
E1 on nerve regeneration. Mechanism of neuroprotective action
remains to be investigated.
In conclusion, the present study demonstrated that local appli-
cation of prostaglandin E1 could accelerate functional recovery after
transection of sciatic nerve. It is available and easily performed. Thus,
doseeresponse studies should be conducted for prostaglandin E1 to
determine the combination of the graft and the compound that
achieve maximal efﬁcacy in nerve transection models.
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